Vitamin A Status in Preterm Infants Is Associated with Inflammation and Dexamethasone Exposure

Madelaine Eloranta Rossholt1,2,3, Kristina Wendel1,3, Marianne Bratlie2

  • 1Department of Neonatal Intensive Care, Oslo University Hospital, 0450 Oslo, Norway.

Nutrients
|January 21, 2023
PubMed

Insights

Very premature infants (<29 weeks gestation) often have vitamin A deficiency, increasing bronchopulmonary dysplasia risk. Inflammation and dexamethasone treatment impact vitamin A levels, requiring careful monitoring in these vulnerable infants.

Area of Science:

  • Neonatalogy
  • Nutritional Biochemistry
  • Pediatric Pulmonology

Background:

  • Vitamin A is crucial for lung development, and deficiency is linked to bronchopulmonary dysplasia risk.
  • Preterm infants, especially those <29 weeks gestation, may have altered vitamin A status.
  • Inflammation and corticosteroid use are common in preterm infants and may affect nutrient levels.

Purpose of the Study:

  • To investigate vitamin A status in preterm infants (<29 weeks gestation).
  • To evaluate the impact of inflammation and postnatal dexamethasone exposure on blood vitamin A concentrations.
  • To analyze factors associated with vitamin A deficiency in early life.

Main Methods:

  • Secondary cohort analysis of the ImNuT trial (NCT03555019).
  • Measurement of vitamin A (retinol) biochemistry, intake, inflammatory markers (interleukin-6), and dexamethasone exposure.
  • Comparison of vitamin A levels between dexamethasone-exposed and unexposed infants.

Main Results:

  • Infants exposed to dexamethasone showed significantly higher vitamin A concentrations after four weeks (1.0 vs. 0.56 µmol/L, p < 0.001).
  • Pretreatment retinol levels were lower in the dexamethasone group, with 88% deficiency at one week versus 60% in the unexposed group.
  • Small size for gestational age, mechanical ventilation, and elevated interleukin-6 were negatively associated with first-week retinol.

Conclusions:

  • Preterm infants (<29 weeks gestation) are at high risk of vitamin A deficiency, even with recommended intakes.
  • Inflammation and dexamethasone exposure significantly influence vitamin A status in preterm infants.
  • Clinical interpretation of vitamin A status requires consideration of inflammatory markers and dexamethasone treatment.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
408
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
5.4K
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
870